"Testing Your Baby For Metabolic Disorders"

Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center

Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival

Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection

Novel CRISPR Imaging Technology Reveals Genes Controlling Tumor Immunity

Mount Sinai Researchers: Why COVID-19 May Be Less Common in Children Than Adults

Mount Sinai Launches App and First Campaign of The Resilience Project to Develop New Treatments and Preventive Care for Diseases

Mount Sinai Researchers Identify 20 Novel Gene Associations With Bipolar Disorder

Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment

"Researchers Develop Prostate Cancer Prediction Tool That Has Unmatched Accuracy"

Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases